Growth Metrics

Pineapple Express Cannabis (PNXP) EBITDA (2018 - 2025)

Pineapple Express Cannabis (PNXP) has disclosed EBITDA for 8 consecutive years, with $20459.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 1739.34% to $20459.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$638461.0 through Oct 2025, down 6993.22% year-over-year, with the annual reading at -$16857.0 for FY2025, 71.67% up from the prior year.
  • EBITDA hit $20459.0 in Q4 2025 for Pineapple Express Cannabis, up from $16658.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $32795.0 in Q1 2021 to a low of -$659293.0 in Q2 2025.
  • Historically, EBITDA has averaged -$36406.8 across 5 years, with a median of -$2865.5 in 2023.
  • Biggest YoY gain for EBITDA was 1739.34% in 2025; the steepest drop was 18132.66% in 2025.
  • Year by year, EBITDA stood at $1027.0 in 2021, then plummeted by 466.99% to -$3769.0 in 2022, then surged by 43.88% to -$2115.0 in 2023, then soared by 40.99% to -$1248.0 in 2024, then soared by 1739.34% to $20459.0 in 2025.
  • Business Quant data shows EBITDA for PNXP at $20459.0 in Q4 2025, $16658.0 in Q3 2025, and -$659293.0 in Q2 2025.